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cancers showed no vessel invasion or positive cytology results. There 
was no correlation between tumor size, TDR, and subtype. No mortal-
ity or recurrence has occurred, but one patient developed postoperative 
pneumothorax.
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Induction chemoradiotherapy for pancoast tumors with N2 disease
Zengerink, Hans1 Mollema, Robert2 Oosterhuis, Wolter2 Paul, Rick2 
1 VU Medical Centre Amsterdam, The Hague, The Netherlands 2 VU 
medical Centre Amsterdam, Amsterdam, The Netherlands 
Introduction: Pancoast tumors are seen as a subgroup of lungcancer 
that behave differently from most other non small cell lungcancers. 
These tumors tend to behave more aggressively locally and metastasize 
more rapidly. Therefore their treatment should also be more aggressive. 
Our center’s experience with Pancoast tumors will be discussed and 
compared with current literature to asses the effects of induction 
chemoradiotherapy on the outcome. Based on these results a proposal 
for treatment will be advocated.
Methods: We retrospectively analyzed the records of all patients with 
Pancoast tumors treated with a multimodality approach at our institu-
tion from july 2001 through January 2007 and compared them with 
recent literature. 
Results: Twenty-six patients were in the study cohort. Because two 
patients failed to receive both chemotherapy and radiotherapy, we 
eventually included 24 patients (7 women, 17 men). The mean age was 
60 years (range, 40-78 years)
There were 18 patients with T3 tumors. 7 patients were proven N2 
positive after a positive PET scan and following mediastinoscopy. 
The chemotherapy regimens consisted of gemcitabine+carboplatin or 
etoposide+carboplatin. Chemotherapy was concurrently or sequentially 
given with external beam radiotherapy delivered in daily fractions 
for a total dose of 46 Gy in most patients. 7 patients with N2 disease 
underwent re-mediastinoscopy after completed induction therapy, with 
all proven negative N2 lymph nodes. 
Postoperative complications occurred in 8 patients (36 without any 
postoperative mortality. Although in 8 patients (36%) there was still vi-
able tumor in the pathologic specimen, we achieved complete resection 
in all patients but 1. There were no positive N2 nodes in the deﬁni-
tive pathologic specimen. In 2 patients with N2 positive nodes before 
induction therapy, there were postoperative positive N1 nodes in the 
specimen. Mean length of follow-up was 19 months (2-58). 6 patients 
died, 2 patients because of locoregional recurrence, 3 patients due to 
metastasis and 1 patient died of cardial cause. 4/12 patients with a fol-
low-up of more than two years died as a result of recurrent malignancy. 
Conclusions: Preoperative Chemo-Radiotherapy results in a high 
percentage of radical resections. Postoperative complications are more 
frequent. The subgroup of patients with a >2 year follow up show high 
survival rates of 66% especially when compared to patients in literature 
that have been treated with surgery alone. The overall results are 
comparable to results reported in literature. Tumor positive mediastinal 
lymph nodes before treatment should not necessarily exclude patients 
from trimodality treatment. The improved survival rates compared to 
surgery alone make this treatment the treatment of choice. 
Therefore we advocate that in this group of patients early multidisci-
plinary staging and organization of treatment is mandatory.
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Effect of neoajuvant chemotherapy in surgery and around surgery 
of patients
Zhang, Yi 
Beijing Lung Cancer Centre CMU, Beijing, China
Background: The aim of this study was to assess feasibility and ef-
ﬁcacy of neoajuvant chemotherapy with NVB and carboplatin followed 
surgery for patients with stage III NSCLC. 
Methods: We report 27 consecutive patients with all staged III NSCLC 
receiving neoadjuvant therapy. mean age was 62.1 years. Cell type was 
squamous 17 cases, adenocarcinoma 7 cases, adenosquamous 3 cases. 
Operations included pneumonectomy(10), pneumonectomy plus ca-
rino-resection(1), bilobectomy(2), lobectomy(10), lobectomy plus lung 
artery plastics(1), exploration(3). Chemotherapy was NP or NC for 1-2 
cycle before surgery. All patients were gived 4-6 cycles chemotherapy 
after operation.
Results: In this group, CR 1, PR 12, SD 13, PD 1.The rate of resection 
was 88.9%. 3 cases of exploration due to tumor invasive heart, cava 
venous. No surgical complication and mortality rate. Bleeding during 
operation was 150-4500ml. 
Conclusion: Destination of neoajuvant chemotherapy is down-stage, 
improving complete resection rate, killing micro-tumor of body, avoid-
ing relapse and distant metastasis, prolong survival and improving 
life quality of patients. Therefore, from our group and foreign papers, 
neoajuvant chemotherapy is safe, effective, not increasing surgical 
mortality and complication after operation.
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Atrial resection in advanced lung cancer
Zharkov, Vladimir V.; Kurchin, Viachaslau P.; Podobed, Alexander V. 
Research Institute of Oncology & Medical Radiology, Minsk, Belarus
Purpose: To assess the results of the surgical treatment of patients with 
non-small cell lung cancer (NSCLC) invading the pulmonary vessels or 
atrium.
Methods: From November 1986 to December 2006, 49 patients 
underwent ñombined pneumonectomy with partial resection of the 
left atrium for lung cancer, without (n=41) and with cardiopulmonary 
bypass and reconstruction bovine pericardium graft (n=8).
Results: Of the 49 patients (median age of 58,6 years, range 41 to 75 
years), 47 were men (96%) and 2 were women. Pathologic analysis of 
the specimens identiﬁed 26 patients (53%) with N2 disease, 22 patients 
(45%) with N1 disease, and 1 patient with N0 disease. The T status 
was pT4 in 35 patients, pT3 in 14 patients. The myocard in border of 
resection was detected by microscopy. Histology was squamous cell 
carcinoma in 37 patients, adenocarcinoma in 4, large cell carcinoma 
in 2, mucoepidermoid carcinoma in 1 and adenoid cystic carcinoma in 
1. 8 patients received a preoperative chemotherapy (n = 2) or radio-
therapy (n = 6). 31 patients (63,2%) underwent right pneumonectomy. 
Only left atrium was resected in 34 patients, two organs in 10 patients, 
and three organs in 5 patient. The superior vena cava was resected in 2 
patients, muscular coat of esophagus in 3, the adventitia of the aorta in 
3, the trachea in 9, diaphragma in 1 and the pulmonary artery in 2. The 
operative mortality rate was 6,6% (n = 3). Non-fatal major complica-
tions occurred in 6 patients (12,2%). The survival rate, calculated with 
the Kaplan-Meier method, was estimated as 61% at 1 year, 36 % at 3 
years and 24% at 5 years (median 15 months), including the operative 
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mortality. The ﬁve-year survival rate of patients with N2 disease (n=26) 
was 13% and those with N0-1 (n=23) was 29% (p> 0,05).
Conclusions: Radical resection of lung cancer with left atrial is fea-
sible, and it could lead to permanent cure in carefully selected patients.
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Analysis about clinicopathologic characteristics of lung 
adenosquamous carcinoma
Zhouyuan, Zhouyuan1 Wangdong, Wangdong2 
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Objective: In order to improve the efﬁcacy of treatment of lung 
adenosquamous carcinoma, we retrospectively reviewed the clinico-
pathologic characteristics of 63 cases who were surgically treated in 
our hospital. 
Methods: From Jan.1994 to Dec.2004, 63 patients of primary lung 
adenosquamous carcinoma were treated surgically. Their clinical and 
pathological records were reviewed. 
Results: Lung adenosquamous carcinoma comprised 11.5% of total 
patients surgically treated for the primary lung cancer during the 
same period. 12 cases(19.0%) were diagnosed before operation. 49 
cases(77.8%) had lymph nodes metastasis(LNM). The degree of LNM 
was 43.9%. 
Conclusions: Lung adenosquamous carcinoma is a more virulent 
tumor, which exhibited highly aggressive biological behavior and 
higher rate of lymph node metastasis. Its prognosis is worse than other 
NSCLC. To obtain a better effect, multi-modality therapy should be 
used with surgical treatment. 
Pathology
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Thoracocardiovascular surgery and pathology of 255 patients with 
cardiac tumors: 30 years of experience in the Philippine Heart 
Center
Asuncion, Bernadette R.1 Lasaca, Rico P.2 Templo, Felipe S.2 
1 Philippine Society of Pathologists, Quezon City, Philippines 2 Philip-
pine Heart Center, Quezon City, Philippines 
Background: Diseases of the Heart, Vascular, Respiratory System and 
malignant neoplasm remains to be the leading cause of mortality in the 
Philippines. Thoracic surgeons and Pathologists are often faced with di-
agnostic and therapeutic dilemmas when presented with cardiac tumors. 
Most often physicians are caught unaware and the decision to undergo 
surgery is almost always necessary before the patient deteriorates.
Methods: To describe the incidence primary cardiac tumors from 1976 
to 2006 at the Philippine Heart Center based on age, gender and man-
ner of presentation, frequency, localization, implantation site, associ-
ated ﬁndings and histopathologic diagnosis and to review cardiac tumor 
registry, patient records and glass slides. On selected cases, additional 
immunohistochemical studies were done from parafﬁn block tissues. 
We used descriptive statistics, and quantitative variables are expressed 
as mean, range and standard deviation whereas qualitative variables are 
expressed as proportions.
Results: 255 patients underwent thoracocardiovascular surgery (me-
dian sternotomy with cardiopulmonary bypass) with primary cardiac 
tumors established clinically and echocardiographically with histo-
pathologic correlation. All cases were derived from autopsy material 
and / or surgically resected specimen. Primary cardiac tumors were 
benign in 91.8 % and malignant in 8.2 %. Of the total 255 cases, 89% 
were adults, and 11% were pediatric cases. Generally the most common 
tumor is myxoma, (86%) followed by metastatic tumors (1.6%). Main 
affected gender was females in 60% of cases. Average age ranges from 
29 days to 82 years with a mean age of 41 years. The most common 
initial presentation was dyspnea and chest pain. Most patients were in 
sinus rhythm, and the best diagnostic tool was 2D echocardiography. In 
adults, myxomas were the most common tumor whereas rhabdomyoma 
occurred most frequently in the pediatric age group. Myxomas were 
mostly located in the left atrial septum, and in decreasing frequencies, 
the left atrial free wall, right atrial free wall, right ventricle and biatrial 
and more were pedunculated and attached to the interventricular 
septum. Tumor size ranged from 2.5 to 12.5 cms in greatest diameter. 
Metastatic tumors were from the lungs and kidney, which may also 
affect the heart by tumor progression via the inferior vena caval vein. 
Sarcomas were most common malignant tumor in adults. Rhabdomyo-
sarcoma, angiosarcoma, myxosarcoma, leiomyosarcoma and malignant 
ﬁbrous histiocytomas were reported.
Conclusion: The series of neoplasm presented varies in clinical pre-
sentation and is speciﬁc for every tumor. Its symptoms depend on the 
location of tumor, its extent and severity. Although most cardiac tumors 
are benign, they can be lethal despite their histology. The advent of 
cardiac imaging, and cardiac surgery, modern immunohistochemical 
studies have aided in the prompt diagnosis of cardiac tumors. Since 
cardiovascular disease and cancer are both common, precise knowl-
edge is necessary. Cardiac tumors are unique and rare that requires the 
physician’s high degree of suspicion.
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Pathology of rare benign vascular tumors of the thorax
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Background: Vascular lesions of the thorax are extremely rare. 
Few literatures can be obtained and its origin is still a major ﬁeld of 
research. The occurrence of thoracic vascular lesions triggers specu-
lations that these lesions, if left untreated, may further enlarge and 
rupture.
Methods: To present a series of diagnosed cases of vascular lesions of 
the thorax, seen in the Philippine Heart Center in the last 10 years, such 
as
(1) Cardiac Hemangioma Obstructing The Right Ventricular Outﬂow 
Tract: A rare case of a 35-year-old female who presented with easy 
fatigability and exertional dyspnea. Imaging studies revealed a cardiac 
mass obstructing the right ventricular outﬂow tract. The diagnosis of 
vascular malformation consistent with cardiac hemangioma was con-
ﬁrmed on histopathologic examination. The postoperative course was 
uneventful.
